# Comparing Effectiveness of CSE Versus DPE for Labor Analgesia

> **NCT05068661** · PHASE4 · COMPLETED · sponsor: **Duke University** · enrollment: 101 (actual)

## Conditions studied

- Labor Pain

## Interventions

- **DRUG:** Ropivacaine 0.1% Injectable Solution
- **DRUG:** Bupivacaine 0.25% Injectable Solution

## Key facts

- **NCT ID:** NCT05068661
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-11-21
- **Primary completion:** 2023-12-07
- **Final completion:** 2023-12-07
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2024-11-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05068661

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05068661, "Comparing Effectiveness of CSE Versus DPE for Labor Analgesia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05068661. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*